Studies assessed, either directly or indirectly, the role of GnRH in leptin-mediated stimulation of LH release in cattle before and after sexual maturation. In experiment 1, the objectives were to determine whether leptin could acutely accelerate the frequency of LH pulses, and putatively GnRH pulses, in prepubertal heifers at different stages of development. In experiment 2, we determined directly whether acute, leptin-mediated increases in LH secretion in the fasted, mature female are accompanied by an increase in GnRH secretion. Ten-month-old prepubertal heifers (experiment 1) fed normal- (n = 5) and restricted-growth (n = 5) diets received three injections of saline or recombinant ovine leptin (oleptin; 0.2 microg/kg body weight, i.v.) at hourly intervals during 5-h experiments conducted every 5 wk until all normal-growth heifers were pubertal. Leptin increased mean concentrations of circulating LH regardless of diet, but pulse characteristics were not altered at any age. In experiment 2, ovariectomized, estradiol-implanted cows (n = 5) were fasted twice for 72 h and treated with either saline or oleptin i.v. (as in experiment 1) on Day 3 of each fast. Leptin increased plasma concentrations of LH and third ventricle cerebrospinal fluid concentrations of GnRH, and increased the amplitude of LH and the size of GnRH pulses, respectively, on Day 3 of fasting compared to saline. Overall, results indicate that leptin is unable to accelerate the pulse generator in heifers at any developmental stage. However, leptin-mediated augmentation of LH concentrations and pulse amplitude in the nutritionally stressed, mature female are associated with modifications in GnRH secretory dynamics.

Serum concentrations of leptin increase linearly from approximately 16 wk before until the week of pubertal ovulation in beef heifers. To test the hypothesis that exogenous leptin can hasten the onset of puberty in heifers, we examined the effects of chronic administration of recombinant ovine leptin (oleptin) on timing of puberty, pulsatile and GnRH-mediated release of LH, and plasma concentrations of GH, IGF-I, and insulin. Fourteen fall-born, prepubertal heifers (Brahman x Hereford, 12 to 13 mo; 304.7+/-4.12 kg) were used. Heifers were stratified by age and BW and assigned randomly to one of two groups (seven animals per group): 1) Control; heifers received s.c. injections of saline twice daily (0700 and 1900) for 40 d; and 2) Leptin; heifers received s.c. injections of oleptin (19.2 microg/kg) twice daily at 0700 and 1900 for 40 d. Blood samples were collected at 10-min intervals for 5 h on. d 0, 5, 10, 20, 30, and 40, and twice daily, just before each treatment injection, throughout the study. On d 41, heifers received i.v. injections of GnRH at 0 (0.0011 microg/kg) and 90 min (0.22 microg/kg), with additional sampling for 5.5 h to examine releasable pools of LH. Diets promoted a gain of 0.32+/-0.09 kg/d, which did not differ between groups. Plasma concentrations of leptin increased markedly in leptin-treated heifers and were greater (P < 0.001) than controls throughout (27.8+/-0.8 vs. 4.9+/-0.12 ng/mL). None of the heifers reached puberty during the experiment, but did so within 45 d of its termination. Mean concentrations of plasma LH, GH, IGF-I, and insulin were not affected by treatment, nor was there an overall effect on the frequency of LH pulses. However, a treatment x day interaction (P = 0.02) revealed that the frequency of LH pulses (pulses/ 5 h) was greater (P = 0.03) in controls (3.6+/-0.36) than in leptin-treated heifers (1.7+/- 0.28) on d 10. Characteristics of GnRH-induced release of LH were not affected by treatment. In summary, chronically administered leptin failed to induce puberty or alter endocrine characteristics in beef heifers nearing the time of expected puberty.

We have shown recently that fasting permits leptin to modulate both luteinizing hormone (LH) and insulin secretion in cows. In rodents, leptin causes divergent effects on LH and insulin release that are dose dependent. To test the hypothesis that leptin effects on LH and insulin secretion in fasted cows are dose related, we examined the effects of various doses of recombinant ovine leptin (oleptin) in mature cows. Twenty ovariectomized beef cows, each bearing an estradiol implant to maintain basal estradiol concentrations, were used. All cows were fasted for 60 hr with free access to water and were assigned randomly to one of four groups (n = 5/group): 1) saline control; 2) leptin, 0.2 μg/kg; 3) leptin, 2.0 μg/kg; and 4) leptin, 20 μg/kg body wt. Blood samples were collected at 10-min intervals for 6 hr on Days 0 and 2, with saline or oleptin injected intravenously immediately after the first intensive sample on Day 2 (54 hr). Leptin caused a dose-related increase (P < 0.001) in mean concentrations of circulating LH. Stimulation of LH release by leptin was significant at the lowest (141% of control) and middle (122% of control) doses used, but no increase was observed for the highest dose. Increased mean concentrations of LH appeared to result from an augmentation of basal secretion, as pulse characteristics were not affected. After 54 hr of fasting, plasma insulin concentrations were lowered (P < 0.01) in all treatment groups compared to Day 0. After leptin injections, plasma insulin concentrations increased (P < 0.01) and reached highest concentrations during the first hour of sampling. However, this increase was sustained for several hours only in the intermediate (2.0 μg/kg) dose group. Collectively, our results show that leptin has potent positive effects on both LH and insulin secretion in fasted cows, but the anterior pituitary and endocrine pancreas appear to become downregulated in the presence of excess ligand.

We tested the hypothesis that leptin could prevent fasting-mediated reductions in pulsatile secretion and modify GnRH-mediated release of LH in heifers approaching puberty. Thirteen crossbred, prepubertal heifers (13.5-16 mo; 280-350 kg) exhibiting frequencies of pulses of LH between 0.67 and 1 pulse/h, were assigned randomly to two groups: 1). control (n = 6), fasted for 72 h with s.c. injections of saline at 12-h intervals, and 2). leptin (n = 7), fasted for 72 h with s.c. injections of oleptin (19.2 microg/kg) at 12-h intervals. Blood samples were collected intensively for 6 h on Days 0 and 3. This was followed on Day 3 with sequential administration of physiological (0.0011 microg/kg, i.v.) and pharmacological (0.22 microg/kg, i.v.) doses of GnRH and additional blood sampling. Leptin treatment increased (P = 0.0003) plasma concentrations of leptin 5-6-fold compared to controls. Fasting caused a marked decline (P = 0.01) between Days 0 and 3 in the frequency of LH pulses in controls; however, this effect was prevented in the leptin group, with pulse frequency increasing (P < 0.008) from Day 0 to 3. Leptin treatment increased GnRH-induced release of LH at both low (P = 0.04) and high (P = 0.02) doses. Plasma insulin and insulin-like growth factor-1 were reduced by fasting and unaffected by leptin. Leptin increased mean concentrations of growth hormone. Results indicate, for the first time, that exogenous leptin can prevent fasting-mediated reductions in the frequency of LH pulses and modify GnRH-mediated release of LH in intact, prepubertal heifers.

This study aimed to assess the efficiency hormonal treatment in the postpartum fertility of nursing beef cows. Seventy-three cows (Hereford x Nellore) raised extensively, with body, condition ranging from 2 to 4 were randomly allotted in three groups. The GSED group, with 25 cows, received an intravaginal device (ID) of 250mg of medroxiprogesteron acetate and 500mg of recombinant bovine somatotropin (bST-r: day 0). After the ID withdrawal (date 7), the cows received 0.5mg of estradiol cipionate: their calves were temporarily weaned for 72 hours. In the SED group, 25 cows received a similar treatment, however, somatotropin was not used. In the control group, 23 cows were temporarily separated from their calves for 72 hours and did not receive any, hormonal treatment. The cows Were put together with the bulls for 30 days just after ID withdrawal. The cows were weighted and assessed,for body condition at day 0 and just after bulls withdrawal. The cows lost weight in an average of 0.648 kg/day, and 56.5%, 33.3%, and 26.1%, of estrous rates were observed, respectively for the GSED, SED and control groups (GSED vs. SED, P=0.0001; GSED vs, control, P=0.0007; SED vs. control, P=0.53). The pregnancy rates were 21.7%, 8.3%, and 13.0%, respectively for the GSED, SED and control groups (P=0.16), The results showed that the hormonal program associated with temporary, 72-hour calf removal did not increase conception rate of cows that loosed weight from 50 to 70 days postpartum.

The reproduction effects of bovine viral diarrhea virus type-2 (BVDV-2) infection were investigated in ewes inoculated with a non-cytopathic BVDV-2 isolate at three stages of gestation. Virus inoculation was followed by a transient viremia, accompanied by a transient and mild hyperthermia and nasal discharge in a few animals. Some ewes were sacrificed at different time-points after virus inoculation to study the kinetics of fetal infection. Infectivity and viral antigens were detected in placentomes from day 7 to 36 post-inoculation (pi) and in fetal fluids and tissues between days 10 and 28 pi. Cardiac petechial hemorrhages and hemoperitonium accompanied by a severe fibrinous ulcerative placentitis were observed in fetuses examined at days 21, 28 and 36 pi. Inoculation of ewes at days 55–60 of gestation resulted in a prolonged virus replication in placentomes and fetal tissues; ewes that were allowed to proceed with pregnancy had 77% of abortions or fetal and perinatal deaths. Seven stillbirths, unviable and viable lambs born to these ewes were virus-positive at birth. Infectious virus was repeatedly isolated from leukocytes of two lambs up to 2 and 6 months of age, indicating they were persistently infected. Ewes inoculated at days 65–70 of gestation had 66.6% of fetal and perinatal losses. Three viable lambs born to these ewes were healthy, BVDV antibody-positive and virus-negative. A transient viral replication in placentomes and in a few fetal tissues, followed by the rise of fetal neutralizing antibodies and virus clearance was the result of inoculating ewes at days 120–125 of gestation. Lambs born to these ewes were healthy, antibody-positive and virus-negative. These results demonstrate that the biology of BVDV-2 infection in pregnant sheep is essentially similar to that of BVDV-1 in pregnant cattle and sheep. These features make this species an attractive animal model for studying the pathogenesis of congenital BVDV-2 infection.

O objetivo deste trabalho foi verificar as ações do fator de crescimento derivado das plaquetas (PDGF; P), da insulina (I), do retinol (R) e de suas associações (PI, PIR, IR e PR) na maturação nuclear (MN) de oócitos bovinos e suas conseqüências no desenvolvimento embrionário (DE). O meio básico para maturação dos oócitos nos diferentes tratamentos foi o TCM-199 modificado acrescido de PVA (controle). No DE, foram utilizados os grupos R, PIR, IR, um controle negativo (PVA) e um controle positivo, contendo soro fetal bovino e gonadotrofinas (SFBHOR). Os fatores P, I, R e suas associações não aceleraram a MN em 7h mas sim após 18h (P<0,001), com exceção dos tratamentos R e PR, nos quais as percentagens de metáfase II foram, respectivamente, de 4,7% e 8,3%, similares à obtida no grupo-controle (0,0%). Considerando um nível de significância de P<0,0001 em comparação ao grupo-controle, os maiores índices de metáfase II foram obtidos na presença das associações IR (19,0%) e PIR (21,3%). No DE, R (18,3%), PIR (13,9%) e IR (10,6%) incrementaram os índices de clivagem, comparados ao PVA (0,0%; P<0,001), porém não atingiram os índices do grupo SFBHOR (53,8%; P<0,001). Conclui-se que insulina e PDGF aceleram a MN e suas ações são potencializadas pelo retinol. Os índices de clivagem de oócitos maturados na presença de R, IR e PIR são superiores aos do PVA, mas significativamente inferiores aos maturados em SFBHOR.

Este trabalho teve por objetivo avaliar a eficiência de tratamentos hormonais sobre a fertilidade de vacas de corte no pós-parto com diferentes condições corporais, durante a estação de monta de outono. Setenta e três vacas pluríparas cruzadas (Hereford x Nelore) criadas extensivamente, com condição corporal entre 2 e 4, foram pesadas e distribuídas em três grupos experimentais. O grupo GSED, constituído por 25 vacas, recebeu pessário vaginal (dia 0) contendo 250mg de acetato de medroxiprogesterona e 500mg de somatotropina bovina recombinante (bST-r). Na retirada dos pessários (dia 7), as vacas receberam 0,5mg de cipionato de estradiol e procedeu-se o desmame temporário dos bezerros por 72 horas. No grupo SED, 25 vacas receberam tratamento semelhante ao grupo GSED, porém não receberam bST-r. No grupo-controle, as 23 vacas somente foram separadas dos seus bezerros por 72h. Quando da retirada dos pessários as vacas foram colocadas com touros por 30 dias. Os animais foram pesados e avaliados quanto à condição corporal no início do experimento e na retirada dos touros (dia 37). Foi constatada perda média de peso de 0,648 kg/dia e os percentuais de estro foram de 26,1%, 33,3% e 56,5%, respectivamente, para os grupos controle, SED e GSED. O diagnóstico de gestação, realizado pela palpação retal 60 dias após a retirada dos touros, indicou percentuais de prenhez de 13,0%, 8,3% e 21,7%, respectivamente, para os grupos controle, SED e GSED (P=0,16), demonstrando que os programas hormonais adotados não foram eficientes no incremento das taxas de prenhez de vacas que perdiam peso entre 50 e 70 dias após o parto.

O objetivo deste trabalho foi verificar as ações do fator de crescimento derivado das plaquetas (PDGF; P), da insulina (I), do retinol (R) e de suas associações (PI, PIR, IR e PR) na maturação nuclear (MN) de oócitos bovinos e suas conseqüências no desenvolvimento embrionário (DE). O meio básico para maturação dos oócitos nos diferentes tratamentos foi o TCM-199 modificado acrescido de PVA (controle). No DE, foram utilizados os grupos R, PIR, IR, um controle negativo (PVA) e um controle positivo, contendo soro fetal bovino e gonadotrofinas (SFBHOR). Os fatores P, I, R e suas associações não aceleraram a MN em 7h mas sim após 18h (P<0,001), com exceção dos tratamentos R e PR, nos quais as percentagens de metáfase II foram, respectivamente, de 4,7% e 8,3%, similares à obtida no grupo-controle (0,0%). Considerando um nível de significância de P<0,0001 em comparação ao grupo-controle, os maiores índices de metáfase II foram obtidos na presença das associações IR (19,0%) e PIR (21,3%). No DE, R (18,3%), PIR (13,9%) e IR (10,6%) incrementaram os índices de clivagem, comparados ao PVA (0,0%; P<0,001), porém não atingiram os índices do grupo SFBHOR (53,8%; P<0,001). Conclui-se que insulina e PDGF aceleram a MN e suas ações são potencializadas pelo retinol. Os índices de clivagem de oócitos maturados na presença de R, IR e PIR são superiores aos do PVA, mas significativamente inferiores aos maturados em SFBHOR.The aim of the present study was to determine the effect of platelet-derived growth factor (PDGF; P), insulin (I) retinol, (R) and their interactions (PI, PIR, IR and PR) on oocyte nuclear maturation (NM) and, consequent, embryonic development (ED). The basic medium for oocyte maturation in the treatments was the modified TCM-199, supplemented with PVA (control). To study the embryonic development, the oocytes were divided in three treatments, R, PIR e IR, a negative (PVA) and a positive control group (containing calf fetal serum and gonadotrophic hormones; FCSHOR). The PDGF, insulin, retinol and their interactions did not change the kinetic of the NM, in seven hours of culture (P=0.4492) but it changed after 18 hours of maturation (P<0.001) except in the treatments R and PR (P<0.001), in which the percentages of metaphase II were, respectively, 4.7% and 8.3%. These results were similar to the control group (0.0%). Considering a significant level of P<0.0001 in comparison to the control group, the higher rates of metaphase II were obtained in the presence of IR (19.0%) and PIR (21.3%). The higher rates of MII were observed when the oocytes were matured in the presence of insulin and retinol. In the embryonic development, R (18.3%), PIR (13.9%) and IR (10.6%) increased the rate of cleavage when compared to PVA group (0.0%; P<0.001). However, the oocytes were not competent enough to reach the rate obtained in the FCSHOR group (53.8%; P<0.001). In conclusion, insulin and PDGF accelerate NM and their effects are enhanced by retinol. In the embryonic development, oocytes matured in the presence of either R, IR or PIR have higher cleavage rate than PVA group but lower than those matured in the FCSHOR group.

The aim of the present study was to determine the effect of platelet-derived growth factor (PDGF: P), insulin (1) retinol, (R) and their interactions (PI, PIR, IR and PR) on oocyte nuclear maturation (NM) and, consequent, embryonic development (ED). The basic medium for oocyte maturation in the treatments was the modified TCM-199, supplemented with PVA (control). To study the embryonic development, the oocytes were divided in three treatments, R, PIR e IR, a negative (PVA) and a positive control group (containing calf fetal serum and gonadotrophic hormones; FCSHOR). The PDGF, insulin, retinol and their interactions did not change the kinetic of the NM, in seven hours of culture (P=0.4492) but it changed after 18 hours of maturation (P<0.001) except in the treatments R and PR (P<0.001), in which the percentages of metaphase II were, respectively, 4.7% and 8.3%. These results were similar to the control group (0.0%). Considering a significant level of P<0.0001 in comparison to the control group, the higher rates of metaphase II were obtained in the presence of IR (19.0%) and PIR (21.3%). The higher rates of MII were observed when the oocytes were matured in the presence of insulin and retinol. In the embryonic development, R (18.3%), PIR (13.9%) and IR (10.6%) increased the rate of cleavage when compared to PVA group (0.0%; P<0.001). However, the oocytes were not competent enough to reach the rate obtained in the FCSHOR group (53.8%; P<0.001). In conclusion, insulin and PDGF accelerate NM and their effects are enhanced by retinol. In the embryonic development, oocytes matured in the presence of either R, IR or PIR have higher cleavage rate than PVA group but lower than those matured in the FCSHOR group.